Skip to main content

Planet 13 Announces Q1 2026 Financial Results

Q1 2026 Revenue of $21.1 million Q1 2026 Net loss of $8.1 million Q1 2026 Adjusted EBITDA loss of $2.3 millionAll figures are reported in United States dollars ($) unless otherwise indicated LAS VEGAS, May 13, 2026 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month period ended March 31, 2026. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). “Q1 was a transition quarter that reflected the cost of the strategic work we executed over the past several quarters including the California exit, the Wagon Trail consolidation in Nevada, and the disciplined cost reduction across the organisation....

Continue reading

Battalion Oil Corporation Announces First Quarter 2026 Financial and Operating Results

HOUSTON, May 13, 2026 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the first quarter of 2026. Key HighlightsThe Company ended the quarter with positive equity of $157.1 million. This provides further basis for the Company to attain compliance with NYSE listing requirements Reduced net debt (gross debt less cash and reinvestment proceeds) to $108.3 million vs $180.2 million in Q4 2025 Divested West Quito Assets for net proceeds of $60.1 million, utilizing $45.6 million to repay amounts outstanding under our Term Loan Executed a private placement to an institutional investor for purchase of common stock at $5.50 per share for total gross proceeds of $15.0 million Converted 7,803 shares of preferred stock to 1.8 million common...

Continue reading

Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights

– Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 – – FDA feedback on use of new form of brilaroxazine in the RECOVER-2 trial and future NDA expected in mid-2026 –– Initiation of patient enrollment in RECOVER-2 registrational Phase 3 trial expected Q3 2026 – CUPERTINO, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today reported financial results for the first quarter ended March 31, 2026 and summarized recent business highlights. “During...

Continue reading

Global Water Resources Reports First Quarter 2026 Results

PHOENIX, May 13, 2026 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, reported results for the first quarter ended March 31, 2026. Unless otherwise noted, all comparisons are to the corresponding period in the prior year. The company will hold a conference call at 1:00 p.m. Eastern time tomorrow to discuss the results (see dial-in information below). Q1 2026 Financial HighlightsTotal revenue increased 6.7% year-over-year (“YoY”) to $13.3 million. The increase was primarily due to the acquisition of seven water systems from Tucson Water in July 2025, organic connection growth, increased consumption and higher rates. Net loss totaled $0.4 million or ($0.01) per share, a decrease of $1.0 million YoY compared to net income of $0.6 million or $0.02 per share in the first...

Continue reading

NanoXplore Reports Results for its Q3-2026

MONTREAL, May 13, 2026 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Corporation”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported its financial results today for the three-month and nine-month periods ended March 31, 2026. All amounts in this press release are in Canadian dollars, unless stated otherwise. Key Financial Highlights Q3-2026Total revenues of $32,347,377 compared to $30,446,165 last year, representing a 6% increase; Adjusted gross margin(1) on revenues from customers of 22.9% compared to 22.4% last year; Loss of $2,646,921 compared to a loss of $1,747,714 last year; Adjusted EBITDA(2) of $1,179,521 compared to $1,420,555 last year; Adjusted EBITDA(2) of $1,237,132 compared to $1,318,149 last year for the Advanced Materials, Plastics and Composite Products segment; Adjusted EBITDA(2)...

Continue reading

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health

Reported revenues of $281.6 million in Q4 and $1,088.7 million in fiscal year 2026 Diluted EPS of $3.91 and Adjusted Diluted EPS of $4.38 in fiscal year 2026 Announces agreement to acquire LaCorium Health, a leader in Australian therapeutic skin care Introducing Outlook for Fiscal 2027 Organic Revenue Growth and Adjusted Diluted EPS of 1% to 3%, respectively, excluding the impact of acquisitionsTARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2026. “Our fiscal 2026 demonstrated the resilience of our business model in a challenging consumer backdrop. Our diversified portfolio of leading brands with deep consumer heritage supports a durable financial profile and drives strong, growing free cash flow....

Continue reading

Intermap Reports First Quarter 2026 Results

Recurring subscription and data revenue exceeds 80% of total revenue Operations near break-even excluding timing and financing related items Enterprise adoption of data-as-a-service platform expands globally, driven by Agentic AI Risk Assistant Government pipeline remains active, funded and positioned for conversion Company affirms guidance of $30-35 million in revenue with a 28% EBITDA margin DENVER, May 13, 2026 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today reported its financial results for the first quarter ended March 31, 2026. Intermap continued to scale its recurring subscription and data revenue in the first quarter, which represented more than 80% of total revenue. The quarter highlights growing...

Continue reading

Aeluma Announces Third Quarter Fiscal 2026 Financial Results

Recently Secured More Than $4 Million in Contracts for Quantum Dot Lasers and Materials Received NASA Award for Integrated Quantum Dot Lasers   Announced Partnerships with Tower Semiconductor and Sumitomo Chemical Advanced Technologies for Wafer Production and Fabrication Appointed Vice President of Materials Operations and Vice President of Strategic Partnerships and Ecosystem Cash and Cash Equivalents as of March 31, 2026 of $37.8 MillionGOLETA, Calif., May 13, 2026 (GLOBE NEWSWIRE) — Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its third quarter of fiscal 2026 ended March 31, 2026. Management Commentary “This quarter reinforced Aeluma’s strategy as we have experienced a major...

Continue reading

Park Dental Partners Announces First Quarter 2026 Results

MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) — Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter financial results for 2026.   Summary financial results are listed below and in the accompanying supplemental financial tables.(Unaudited, in millions, except per share data, and Doctor counts)  Three Months EndedMarch 31,    2026       2025   Change  Revenue $62.7     $59.0   6.2%  Gross Margin $6.4     $9.9   (35.3%)  Gross Margin percentage   10.2%       16.7%   (650 bps)  Net Income (Loss) ($0.4)     $1.6   (124.9%)  Diluted EPS ($0.09)     $0.88   ($0.97)                   Adjusted Gross Margin(a) $12.2     $11.9   2.6%  Adjusted Gross Margin Percentage(a)   19.5%       20.2%   (70...

Continue reading

USA Rare Earth Reports First Quarter 2026 Financial Results

STILLWATER, Okla., May 13, 2026 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), an emerging global leader in rare earths, today announced its financial and operational results for the first quarter ended March 31, 2026. Executive Commentary “The first quarter of 2026 was a period of fundamental transformation for USA Rare Earth, defined by the successful execution of our $1.5 billion PIPE financing and the announcement of an agreement for the 100% economic consolidation of our Round Top project,” said Barbara Humpton, CEO of USA Rare Earth. “These steps, alongside the commissioning of Phase 1a at Stillwater, provide additional resources and operational momentum that continue to propel USA Rare Earth’s mission to become the global rare earth leader and serve the most demanding sectors of the modern economy....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.